Pharmaceutical Executive: June 2023

2023 Pharm Exec Top 50 Companies

June 10, 2023

Features

43

6

With the sales boom from COVID-19 products now in the rear-view, a resetting is underway for those in Pharm Exec’s listing of the top biopharma producers—shifting attention to new Rx roads ahead and the steady strategies needed to navigate a bumpy business terrain.

Great Leaders Listen

June 10, 2023

Executive Profile

43

6

Jag Dosanjh, president of US neuroscience and eye care for AbbVie and HBA’s 2023 honorable mentor of the year, shares what leadership qualities are most important in today’s “people industry”—and the impact more voices can make in stakeholder communication and messaging.

Embracing Generative AI: Why Its Disruption is Positive for Pharma

June 09, 2023

Features

43

6

The new era of generative AI is poised to impact pharma marketing and engagement in powerful and lasting ways. But amid all the technological praise, what are the key considerations brand teams must navigate?

Tapping NPs and PAs in Life Sciences Marketing

June 09, 2023

Features

43

6

Amid the shifting focus from primary care to specialty care, using data-driven tactics can create tailored campaigns and meaningful relationships with nurse practitioners and physician assistants.

Pharma Trends & Trust

June 07, 2023

From the Editor

43

6

This month, we deliver deep dives into the industry's commercial output and outlook and how drugmakers are faring in their public trust mandate—two areas where respective growth pursuits can often go hand-in-hand.

FDA Eyes New Strategies to Spur Gene Therapy Development

May 03, 2023

Column

43

6

Agency seeks added resources and new approaches to accelerate more of these promising treatments to the market.